PLUSS Advanced Technologies launches Brrf PLUSS Jackets
Pluss Advanced Technologies has launched a cooling wearable technology that can be worn by workers who are outdoors, such as…
Author: Per Arnesen
EVERSANA Completes Integration of Healthware Group and Strengthens Its Global Agency Network EVERSANA INTOUCH With Addition of New Full-Service Affiliate
EVERSANA, a leading provider of global commercial services to the life sciences industry, today unveiled a new full-service affiliate in…
Endurance Athlete Andrew Linder Partners with OS1st® for Monumental Cross-Country Run
OS1st®, a leader in performance gear, is thrilled to announce its collaboration with endurance athlete Andrew Linder for an unprecedented cross-country…
Formosa Pharmaceuticals and AimMax Therapeutics Receive FDA Approval for Clobetasol Propionate Ophthalmic Suspension 0.05%, for the Treatment of Post-Operative Inflammation and Pain Following Ocular Surgery
Taiwan-based Formosa Pharmaceuticals (6838.TWO) and AimMax Therapeutics (United States) announced today that the U.S. Food and Drug Administration (FDA) has…
YASHODA HOSPITALS, Hyderabad SUCCESSFULLY TREATS ELDERLY MAN WITH CA. BUCCAL MUCOSA INFILTRATING INTO MANDIBLE
Yashoda Hospitals (Malakpet) Hyderabad, a leading healthcare institution, has successfully treated an elderly man aged 57 from Warrangal suffering from…
Constant Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of TXA127 in Ischemic Stroke Recovery
Constant Therapeutics LLC, a biopharmaceutical company focused on the development of treatments impacting the Alternative Renin-Angiotensin System, today announced that the…
Signia Marks a New Era with the Inauguration of its 350th BestSound Center in Partnership with HearSens Hearing Clinic in Hyderabad
Signia, a distinguished brand within the WS Audiology group and a leader in hearing aid innovation, celebrates a significant milestone…
Johnson & Johnson Submits Supplemental Biologics License Application and New Drug Application to U.S. FDA Seeking Approval of RYBREVANT® (amivantamab-vmjw) Plus Lazertinib for the Treatment of Patients with EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC)
Johnson & Johnson announced today the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug…
Ludhiana’s Simran Sound Centre Elevates Regional Healthcare Standards
Widex India has made a significant stride in healthcare with the opening of the Simran Sound Centre in Ludhiana, Punjab.…
Oxford Nanopore and Day Zero Diagnostics Partner to Develop a New Class of Bloodstream Infection Diagnostics
Oxford Nanopore, the company delivering a new generation of nanopore-based molecular sensing technology, and Day Zero Diagnostics (DZD), an infectious disease diagnostics…